Biogen BIIB
NASDAQ BIIB
$253.40 +2.92 (+1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Biogen (BIIB) Dividends Paid - Common and Preferred (2017 - 2018)

Updated

Analysis

Biogen (BIIB) Dividends Paid - Common and Preferred (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div Paid (Total) (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 1.54 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 3.23 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 3.07 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 2.10 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -8.24 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.36 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.04 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 2.45 Bn
10 Biogen 37.46 Bn 26.77 Bn 2.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 36.40 Mn
Mar 31, 2017 302.70 Mn
API Access

Biogen Dividends Paid - Common and Preferred API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=dividends-paid-common-and-prefferd&ticker=BIIB&period=max&api_key=YOUR_API_KEY